These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27758855)

  • 1. Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.
    Matsui Y; Shindo K; Nagata K; Yoshinaga N; Shirakawa K; Kobayashi M; Takaori-Kondo A
    J Biol Chem; 2016 Nov; 291(48):24892-24899. PubMed ID: 27758855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Vif-Mediated Degradation of APOBEC3G through Competitive Binding of Core-Binding Factor Beta.
    Miyagi E; Welbourn S; Sukegawa S; Fabryova H; Kao S; Strebel K
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.
    Fribourgh JL; Nguyen HC; Wolfe LS; Dewitt DC; Zhang W; Yu XF; Rhoades E; Xiong Y
    J Virol; 2014 Mar; 88(6):3309-19. PubMed ID: 24390320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.
    Matsui Y; Shindo K; Nagata K; Io K; Tada K; Iwai F; Kobayashi M; Kadowaki N; Harris RS; Takaori-Kondo A
    Virology; 2014 Jan; 449():82-7. PubMed ID: 24418540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces.
    Hultquist JF; McDougle RM; Anderson BD; Harris RS
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1543-51. PubMed ID: 22725134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.
    Duan S; Wang S; Song Y; Gao N; Meng L; Gai Y; Zhang Y; Wang S; Wang C; Yu B; Wu J; Yu X
    J Biol Chem; 2020 Oct; 295(43):14592-14605. PubMed ID: 32817167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction.
    Duan S; Yu X; Wang C; Meng L; Gai Y; Zhou Y; Gu T; Yu B; Wu J; Yu X
    J Virol; 2022 Sep; 96(17):e0055522. PubMed ID: 35950859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components.
    Zhou X; Evans SL; Han X; Liu Y; Yu XF
    PLoS One; 2012; 7(3):e33495. PubMed ID: 22479405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
    Zhang W; Du J; Evans SL; Yu Y; Yu XF
    Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CBFβ enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G.
    Miyagi E; Kao S; Yedavalli V; Strebel K
    J Virol; 2014 May; 88(9):4839-52. PubMed ID: 24522927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFβ recruitment and A3G suppression.
    Zhou X; Han X; Zhao K; Du J; Evans SL; Wang H; Li P; Zheng W; Rui Y; Kang J; Yu XF
    J Virol; 2014 Mar; 88(5):2555-63. PubMed ID: 24352440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolutionarily conserved requirement for core binding factor beta in the assembly of the human immunodeficiency virus/simian immunodeficiency virus Vif-cullin 5-RING E3 ubiquitin ligase.
    Han X; Liang W; Hua D; Zhou X; Du J; Evans SL; Gao Q; Wang H; Viqueira R; Wei W; Zhang W; Yu XF
    J Virol; 2014 Mar; 88(6):3320-8. PubMed ID: 24390335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a tripartite interaction between the N-terminus of HIV-1 Vif and CBFβ that is critical for Vif function.
    Desimmie BA; Smith JL; Matsuo H; Hu WS; Pathak VK
    Retrovirology; 2017 Mar; 14(1):19. PubMed ID: 28302150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and Structural Insights into a Vif/PPP2R5 Complex Elucidated Using Patient HIV-1 Isolates and Computational Modeling.
    Salamango DJ; McCann JL; Demir Ö; Becker JT; Wang J; Lingappa JR; Temiz NA; Brown WL; Amaro RE; Harris RS
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32847850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple lysines combined in HIV-1 Vif determines the responsiveness to CBF-β.
    Ai Y; Ma J
    Biochem Biophys Res Commun; 2015 Feb; 457(3):385-90. PubMed ID: 25582776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vif-CBFβ interaction is essential for Vif-induced cell cycle arrest.
    Du J; Rui Y; Zheng W; Li P; Kang J; Zhao K; Sun T; Yu XF
    Biochem Biophys Res Commun; 2019 Apr; 511(4):910-915. PubMed ID: 30851937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
    Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
    Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Conserved Interface of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Vifs with Cullin 5.
    Gu Q; Zhang Z; Gertzen CGW; Häussinger D; Gohlke H; Münk C
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29263270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential requirements for HIV-1 Vif-mediated APOBEC3G degradation and RUNX1-mediated transcription by core binding factor beta.
    Du J; Zhao K; Rui Y; Li P; Zhou X; Zhang W; Yu XF
    J Virol; 2013 Feb; 87(3):1906-11. PubMed ID: 23175372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction.
    Gai Y; Duan S; Wang S; Liu K; Yu X; Yang C; Li G; Zhou Y; Yu B; Wu J; Wang C; Yu X
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.